Europe Pruritus Therapeutics Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers), By Country and Growth Forecast, 2023 - 2030

The Europe Pruritus Therapeutics Market would witness market growth of 4.1% CAGR during the forecast period (2023-2030).

For severe and ongoing pruritus, systemic medication such as antihistamines, antidepressants, immunosuppressants, and opioid antagonists are administered. These drugs either affect the central nervous system's itch pathway or the underlying cause of pruritus. Light therapy, or phototherapy, uses ultraviolet (UV) light to treat pruritus caused by skin conditions such as psoriasis and irritation. The skin's condition improves with UV light, which helps suppress inflammation and ease itching. Modifying one's lifestyle, avoiding triggers, maintaining proper skin hygiene, utilizing gentle skincare products, and managing anxiety can complement pharmacological treatments and alleviate pruritus.

One of the emerging market trends is the use of cutting-edge technology in creating products to treat fungal infections, including pruritus. This method allows for the use of typically unsoluble medications, increasing the drug's bioavailability and effectiveness in tablet form. Thus, developing and distributing pharmaceuticals using innovative technology helps increase their efficacy, thereby improving therapy alternatives. These technological developments will encourage the market to grow favorably. The market is progressing due to regulatory agencies' increased special designation. Additionally, the market will benefit from profitable growth prospects due to the rise in demand for over-the-counter topical corticosteroids.

The U.K. government's "Future of an Aging Population" study estimates that by 2040, one in seven citizens will be over 75. By 2037, 1.42 million more families, or an increase of 161% over 25 years, are expected to be headed by an individual who is 85 years or older. Over 5.5 million more people are anticipated to contribute to the percentage of working-age people over 50 and at the state pension age (SPA), which is predicted to increase from 26% in 2012 to 34% in 2050. Due to aging-related skin changes and a higher prevalence of specific underlying disorders, elderly people are more likely to experience pruritus. Because of this, the regional market will expand due to the aging population.

The Germany market dominated the Europe Pruritus Therapeutics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $751.4 million by 2030. The UK market is anticipated to grow at a CAGR of 3.3% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 4.9% during (2023 - 2030).

Based on Disease Type, the market is segmented into Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria and Others. Based on Product, the market is segmented into Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Worldwide Pruritus Therapeutics Market is Projected to reach USD 11.2 Billion by 2030, at a CAGR of 4.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bristol Myers Squibb Company, Novartis AG, Pfizer, Inc., Sanofi S.A., Astellas Pharma, Inc., Cara Therapeutics, Inc., GlaxoSmithKline PLC (GSK), Teva Pharmaceuticals Industries Ltd., Amgen, Inc., and AbbVie, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Disease Type

• Atopic Dermatitis
• Allergic Contact Dermatitis
• Urticaria
• Others

By Product

• Corticosteroids
• Antihistamines
• Local Anesthetics
• Counterirritants
• Immunosuppressant
• Calcineurin Inhibitors
• Others

By Distribution Channel

• Drug Stores & Retail Pharmacies
• Hospital Pharmacies
• Online Providers

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Bristol Myers Squibb Company
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• Astellas Pharma, Inc.
• Cara Therapeutics, Inc.
• GlaxoSmithKline PLC (GSK)
• Teva Pharmaceuticals Industries Ltd.
• Amgen, Inc.
• AbbVie, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pruritus Therapeutics Market, by Disease Type
1.4.2 Europe Pruritus Therapeutics Market, by Product
1.4.3 Europe Pruritus Therapeutics Market, by Distribution Channel
1.4.4 Europe Pruritus Therapeutics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis

Chapter 4. Europe Pruritus Therapeutics Market by Disease Type
4.1 Europe Atopic Dermatitis Market by Country
4.2 Europe Allergic Contact Dermatitis Market by Country
4.3 Europe Urticaria Market by Country
4.4 Europe Others Market by Country

Chapter 5. Europe Pruritus Therapeutics Market by Product
5.1 Europe Corticosteroids Market by Country
5.2 Europe Antihistamines Market by Country
5.3 Europe Local Anesthetics Market by Country
5.4 Europe Counterirritants Market by Country
5.5 Europe Immunosuppressant Market by Country
5.6 Europe Calcineurin Inhibitors Market by Country
5.7 Europe Others Market by Country

Chapter 6. Europe Pruritus Therapeutics Market by Distribution Channel
6.1 Europe Drug Stores & Retail Pharmacies Market by Country
6.2 Europe Hospital Pharmacies Market by Country
6.3 Europe Online Providers Market by Country

Chapter 7. Europe Pruritus Therapeutics Market by Country
7.1 Germany Pruritus Therapeutics Market
7.1.1 Germany Pruritus Therapeutics Market by Disease Type
7.1.2 Germany Pruritus Therapeutics Market by Product
7.1.3 Germany Pruritus Therapeutics Market by Distribution Channel
7.2 UK Pruritus Therapeutics Market
7.2.1 UK Pruritus Therapeutics Market by Disease Type
7.2.2 UK Pruritus Therapeutics Market by Product
7.2.3 UK Pruritus Therapeutics Market by Distribution Channel
7.3 France Pruritus Therapeutics Market
7.3.1 France Pruritus Therapeutics Market by Disease Type
7.3.2 France Pruritus Therapeutics Market by Product
7.3.3 France Pruritus Therapeutics Market by Distribution Channel
7.4 Russia Pruritus Therapeutics Market
7.4.1 Russia Pruritus Therapeutics Market by Disease Type
7.4.2 Russia Pruritus Therapeutics Market by Product
7.4.3 Russia Pruritus Therapeutics Market by Distribution Channel
7.5 Spain Pruritus Therapeutics Market
7.5.1 Spain Pruritus Therapeutics Market by Disease Type
7.5.2 Spain Pruritus Therapeutics Market by Product
7.5.3 Spain Pruritus Therapeutics Market by Distribution Channel
7.6 Italy Pruritus Therapeutics Market
7.6.1 Italy Pruritus Therapeutics Market by Disease Type
7.6.2 Italy Pruritus Therapeutics Market by Product
7.6.3 Italy Pruritus Therapeutics Market by Distribution Channel
7.7 Rest of Europe Pruritus Therapeutics Market
7.7.1 Rest of Europe Pruritus Therapeutics Market by Disease Type
7.7.2 Rest of Europe Pruritus Therapeutics Market by Product
7.7.3 Rest of Europe Pruritus Therapeutics Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Bristol Myers Squibb Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Novartis AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Pfizer, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.3.6 SWOT Analysis
8.4 Sanofi S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 Astellas Pharma, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Cara Therapeutics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.5 SWOT Analysis
8.7 GlaxoSmithKline PLC (GSK)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Teva Pharmaceutical Industries Ltd.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Amgen, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. AbbVie, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Approvals & Trials:
8.10.6 SWOT Analysis

TABLE 1 Europe Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 Europe Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 3 Europe Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 4 Europe Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 5 Europe Atopic Dermatitis Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Atopic Dermatitis Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Allergic Contact Dermatitis Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Allergic Contact Dermatitis Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Urticaria Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Urticaria Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 14 Europe Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 15 Europe Corticosteroids Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Corticosteroids Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Antihistamines Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Antihistamines Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Local Anesthetics Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Local Anesthetics Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Counterirritants Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Counterirritants Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Immunosuppressant Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Immunosuppressant Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Calcineurin Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Calcineurin Inhibitors Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 29 Europe Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 30 Europe Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 31 Europe Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 33 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 35 Europe Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 36 Europe Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 37 Europe Pruritus Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 38 Europe Pruritus Therapeutics Market by Country, 2023 - 2030, USD Million
TABLE 39 Germany Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 40 Germany Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 41 Germany Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 42 Germany Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 43 Germany Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 44 Germany Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 45 Germany Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 Germany Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 UK Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 48 UK Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 49 UK Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 50 UK Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 51 UK Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 52 UK Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 53 UK Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 UK Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 55 France Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 56 France Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 57 France Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 58 France Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 59 France Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 60 France Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 61 France Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 62 France Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 63 Russia Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 64 Russia Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 65 Russia Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 66 Russia Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 67 Russia Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 68 Russia Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 69 Russia Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 Russia Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 71 Spain Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 72 Spain Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 73 Spain Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 74 Spain Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 75 Spain Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 76 Spain Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 77 Spain Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 78 Spain Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 79 Italy Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 80 Italy Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 81 Italy Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 82 Italy Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 83 Italy Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 84 Italy Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 85 Italy Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 86 Italy Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 87 Rest of Europe Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 88 Rest of Europe Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 89 Rest of Europe Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 90 Rest of Europe Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 91 Rest of Europe Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 92 Rest of Europe Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 93 Rest of Europe Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 94 Rest of Europe Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 95 Key Information – Bristol Myers Squibb Company
TABLE 96 Key Information – Novartis AG
TABLE 97 Key Information – Pfizer, Inc.
TABLE 98 Key Information – Sanofi S.A.
TABLE 99 key information – Astellas Pharma, Inc.
TABLE 100 Key Information – Cara Therapeutics, Inc.
TABLE 101 Key Information – GlaxoSmithKline PLC
TABLE 102 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 103 Key Information – Amgen, Inc.
TABLE 104 Key information – AbbVie, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Pruritus Therapeutics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Pruritus Therapeutics Market
FIG 4 Porter’s Five Force Analysis: Pruritus Therapeutics Market
FIG 5 Europe Pruritus Therapeutics Market share by Disease Type, 2022
FIG 6 Europe Pruritus Therapeutics Market share by Disease Type, 2030
FIG 7 Europe Pruritus Therapeutics Market by Disease Type, 2019 - 2030, USD Millio
FIG 8 Europe Pruritus Therapeutics Market share by Product, 2022
FIG 9 Europe Pruritus Therapeutics Market share by Product, 2030
FIG 10 Europe Pruritus Therapeutics Market by Product, 2019 - 2030, USD Million
FIG 11 Europe Pruritus Therapeutics Market share by Distribution Channel, 2022
FIG 12 Europe Pruritus Therapeutics Market share by Distribution Channel, 2030
FIG 13 Europe Pruritus Therapeutics Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 Europe Pruritus Therapeutics Market share by Country, 2022
FIG 15 Europe Pruritus Therapeutics Market share by Country, 2030
FIG 16 Europe Pruritus Therapeutics Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Bristol Myers Squibb Company
FIG 18 SWOT Analysis: Novartis AG
FIG 19 SWOT Analysis: Pfizer, Inc.
FIG 20 Swot Analysis: Sanofi S.A.
FIG 21 SWOT Analysis: Astellas Pharma, Inc.
FIG 22 SWOT Analysis: CARA THERAPEUTICS, INC.
FIG 23 SWOT Analysis: GlaxoSmithKline PLC
FIG 24 Swot Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 25 Swot Analysis: Amgen, Inc.
FIG 26 Swot Analysis: AbbVie, Inc.